1. Home
  2. UTSI vs BYSI Comparison

UTSI vs BYSI Comparison

Compare UTSI & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UTStarcom Holdings Corp.

UTSI

UTStarcom Holdings Corp.

N/A

Current Price

$1.95

Market Cap

22.3M

ML Signal

N/A

Logo BeyondSpring Inc.

BYSI

BeyondSpring Inc.

N/A

Current Price

$0.65

Market Cap

25.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UTSI
BYSI
Founded
1991
2010
Country
China
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.3M
25.5M
IPO Year
1999
2016

Fundamental Metrics

Financial Performance
Metric
UTSI
BYSI
Price
$1.95
$0.65
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.6K
★ 128.4K
Earning Date
08-14-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$49.96
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.78
$0.42
52 Week High
$3.63
$2.44

Technical Indicators

Market Signals
Indicator
UTSI
BYSI
Relative Strength Index (RSI) 34.88 55.00
Support Level N/A $0.60
Resistance Level $2.58 $0.85
Average True Range (ATR) 0.19 0.11
MACD -0.03 0.02
Stochastic Oscillator 16.17 56.98

Price Performance

Historical Comparison
UTSI
BYSI

About UTSI UTStarcom Holdings Corp.

UTStarcom Holdings Corp is engaged in providing telecommunication and networking products, solutions and services, focusing on optical networking, carrier-class packet optical, network synchronization, broadband products and a Software Defined Networking (SDN) platform optimized for AI networking infrastructure, mobile backhaul, metro aggregation, broadband access and value-added services. The Company operates through two segments: Equipment, which includes the sale of network infrastructure and application products such as broadband and wireless infrastructure technologies, and Services, which generates maximum revenue and provides support and operational services for equipment products. The Company generates maximum revenue from Japan.

About BYSI BeyondSpring Inc.

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin is a novel brain-penetrant microtubule modulator with dendritic cell maturation and vasculature modulation mechanism, which has the potential to help mitigate acquired resistance from prior immune checkpoint inhibitors (ICI) treatment in cancer patients. It is a Selective Immunomodulating Microtubule-Binding Agent (SIMBA), which may provide multiple therapeutic opportunities.

Share on Social Networks: